Global Pneumococcal Vaccine Market is estimated to be US$ US$13.5 billion by 2030 with a CAGR of 5.3% during the forecast period - by PMI
February 24, 2021 11:05 ET | PMI
Covina CA, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Global Pneumococcal Vaccine Market accounted for US$ US$8.1 billion in 2020 and is estimated to be US$ 13.5 billion by 2030 and is anticipated to...
CapLinked Welcomes Covid-19 Vaccine Manufacturer as Client
February 24, 2021 08:00 ET | CapLinked
LOS ANGELES, Feb. 24, 2021 (GLOBE NEWSWIRE) -- CapLinked, Inc., a developer of cloud-based information control software, announced the addition of life sciences Serum Institute of India as a client....
SpyBiotech and Serum Institute of India announce that the first subjects have been dosed in a Phase I/II trial of a novel virus-like particle vaccine targeting COVID-19
September 08, 2020 03:00 ET | SpyBiotech
OXFORD, United Kingdom, Sept. 08, 2020 (GLOBE NEWSWIRE) -- SpyBiotech, a company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases, today announces that its...
Global COVID-19 Impact on Vaccines & Drugs Market growth is mainly attributed due to growing number of people infected with COVID-19 and rising funding for vaccine development - PMI
June 22, 2020 11:05 ET | PMI
Covina, CA, June 22, 2020 (GLOBE NEWSWIRE) -- The global COVID-19 vaccines market accounted for US$ 2.6 billion in 2020 and is estimated to be US$ 1.5 billion by 2025 and is anticipated to register...